SPC321
Indakateról-asetat eða indakateról-xínafóat, ákjósanlega indakateról-asetat, í samsetningu með mómetasónfúróati og glýkópýrróníum
Status:
UmsóknApplication date:
7.12.2020Application published:
15.1.2021
Max expiry date:
1.7.2032Medicine name:
Enerzair Breezhaler & Zimbus BreezhalerMedicine for children:
No
Timeline
Today
7.12.2020Application
15.1.2021Publication
1.7.2032Expires
Marketing license
IS authorization number:
EU/1/20/1438/001-005 & EU/1/20/1440/001-005Date:
21.7.2020
Foreign authorization number:
EU/1/20/1438 & EU/1/20/1440Date:
3.7.2020
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, Basel CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2044025